Literature DB >> 629982

The role of nonhistone chromosomal proteins in the interaction of prostate chromatin with androgen.receptor complex.

T Y Wang.   

Abstract

Rat prostate nonhistone chromatin proteins were fractionated by sequential extraction with 0.35 M NaCl and 2.0 M NaCl into 0.35 M NaCl-soluble, 2 M NaCl-soluble and -insoluble (residual) fractions. Interactions of [3H]dihydrotestosterone.receptor complex with reconstituted chromatin lacking one of these fractions and with reconstituted hybrid chromatin using spleen fractions indicate that binding of chromatin to androgen.receptor is largely determined by the residual fraction. The residual fraction of prostate also interacts directly with [3H]dihydrotestosterone.receptor complex target tissue-specifically similar to prostate chromatin. The DNA in the residual fraction is mostly bound by nonhistone proteins and the template activity of te residual DNA in transcription is severely restricted. These characteristics are discussed in relation to the acceptor role in the residual fraction in androgen action.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 629982     DOI: 10.1016/0005-2787(78)90117-x

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  3 in total

Review 1.  Purification of a nuclear protein (receptor binding factor-1) associated with the chromatin acceptor sites for the avian oviduct progesterone receptor.

Authors:  J Rejman; J Landers; A Goldberger; D J McCormick; B Gosse; T C Spelsberg
Journal:  J Protein Chem       Date:  1991-12

2.  Nuclear matrix DNA from chicken erythrocytes contains beta-globin gene sequences.

Authors:  P C Hentzen; J H Rho; I Bekhor
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

3.  Monoclonal antibodies specific for tight-binding human chromatin antigens reveal structural rearrangements within the nucleus during the cell cycle.

Authors:  J S Bhorjee; S L Barclay; A Wedrychowski; A M Smith
Journal:  J Cell Biol       Date:  1983-08       Impact factor: 10.539

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.